We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOW icon
326
Dow Inc
DOW
$20.8B
$12.6M 0.06%
230,758
-3,673
-2% -$194K
SHEL icon
327
Shell
SHEL
$239B
$12.6M 0.06%
190,581
-17,892
-9% -$1.27M
TSM icon
328
TSMC
TSM
$2.03T
$12.4M 0.06%
71,496
-632
-0.9% -$108K
HP icon
329
Helmerich & Payne
HP
$3.31B
$12.4M 0.06%
408,012
+83,185
+26% +$2.87M
ZD icon
330
Ziff Davis
ZD
$1.95B
$12.4M 0.06%
254,797
-2,152
-0.8% -$103K
VRTS icon
331
Virtus Investment Partners
VRTS
$1.14B
$12.3M 0.06%
58,766
-702
-1% -$150K
LAMR icon
332
Lamar Advertising Co
LAMR
$16.5B
$12.2M 0.06%
91,262
+8,651
+10% +$1.06M
DVAX
333
DELISTED
Dynavax Technologies
DVAX
$12.2M 0.06%
1,093,572
-16,451
-1% -$181K
IR icon
334
Ingersoll Rand
IR
$33.9B
$12.2M 0.06%
123,938
-6,067
-5% -$564K
C icon
335
Citigroup
C
$222B
$12.1M 0.06%
192,927
+14,858
+8% +$919K
EEFT icon
336
Euronet Worldwide
EEFT
$3.15B
$12M 0.06%
121,434
-1,711
-1% -$173K
NSC icon
337
Norfolk Southern
NSC
$76.1B
$11.9M 0.06%
47,805
-1,526
-3% -$366K
VRNT
338
DELISTED
Verint Systems
VRNT
$11.8M 0.06%
467,324
-6,523
-1% -$201K
GO icon
339
Grocery Outlet
GO
$902M
$11.8M 0.06%
670,101
-8,604
-1% -$163K
VBK icon
340
Vanguard Small-Cap Growth ETF
VBK
$23.2B
$11.7M 0.06%
43,730
+82
+0.2% +$21K
EG icon
341
Everest Group
EG
$15.8B
$11.7M 0.06%
29,779
-385
-1% -$147K
AON icon
342
Aon
AON
$81.4B
$11.6M 0.06%
33,386
+3,205
+11% +$1.05M
CUBE icon
343
CubeSmart
CUBE
$9.62B
$11.5M 0.06%
214,330
+59
+0% +$2.93K
PWR icon
344
Quanta Services
PWR
$88.3B
$11.5M 0.06%
38,647
+287
+0.7% +$75.9K
HOG icon
345
Harley-Davidson
HOG
$2.66B
$11.5M 0.05%
298,071
+11,684
+4% +$423K
ETR icon
346
Entergy
ETR
$52.4B
$11.5M 0.05%
174,476
-79,032
-31% -$4.66M
RLJ icon
347
RLJ Lodging Trust
RLJ
$1.89B
$11.2M 0.05%
1,217,090
-13,033
-1% -$122K
NGVT icon
348
Ingevity
NGVT
$2.59B
$11.1M 0.05%
285,782
-2,855
-1% -$114K
CVS icon
349
CVS Health
CVS
$140B
$11.1M 0.05%
176,549
-156,241
-47% -$9.12M
BWA icon
350
BorgWarner
BWA
$13B
$11M 0.05%
304,243
+93,220
+44% +$3.07M

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.